insights_auto
Why is BSLN up 4.28%?
Dive Deeperchevron_right
BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 73.10
arrow_upward
+4.28%(+3.00) 1D
Nov 3, 5:00:34 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHF 69.90
High
CHF 74.00
Low
CHF 69.40
Mkt. cap
982.66M
Avg. vol.
29.76K
Volume
41.33K
P/E ratio
19.08
52-wk high
CHF 75.80
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
Open
CHF 69.90
High
CHF 74.00
Low
CHF 69.40
Mkt. cap
982.66M
Avg. vol.
29.76K
Volume
41.33K
P/E ratio
19.08
52-wk high
CHF 75.80
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
News stories
From web sources and news partners
Yahoo Finance
·
10 hours ago
Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil